Alopecia patients finally have an FDA-approved hair-loss treatment

The newly approved drug, in two Phase III clinical trials, 32 percent of people with severe alopecia who took 4 milligrams of Olumiant tablets had 80 percent of their hair grow back after 9 months. Suzanne Friedler, MD comments on this breakthrough.